tofenacin has been researched along with Parkinson Disease, Secondary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Capstick, N; Pudney, H | 1 |
| Altamura, AC; De Novellis, F; Mauri, MC; Percudani, M; Vampini, V | 1 |
1 trial(s) available for tofenacin and Parkinson Disease, Secondary
| Article | Year |
|---|---|
A comparative trial of orphenadrine and tofenacin in the control of depression and extrapyramidal side-effects associated with fluphenazine decanoate therapy.
Topics: Clinical Trials as Topic; Depression; Fluphenazine; Humans; Orphenadrine; Parkinson Disease, Secondary | 1976 |
1 other study(ies) available for tofenacin and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Residual neuroleptic-induced parkinsonian symptoms in schizophrenia. A naturalistic study with orphenadrine.
Topics: Adult; Aged; Female; Haloperidol; Humans; Male; Middle Aged; Orphenadrine; Parkinson Disease, Secondary; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1989 |